Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study

被引：0
|
作者：
Myong Cheol Lim
Young-Joo Won
Jiwon Lim
Tahereh Salehi
Chong Woo Yoo
Robert E. Bristow
机构：
[1] University of California,Division of Gynecologic Oncology, Obstetrics and Gynecology, Irvine Medical Center
[2] Center for Uterine Cancer and Center for Clinical Trials,Department of Cancer Control & Population Health
[3] Hospital,Cancer Registration and Statistics Branch
[4] National Cancer Center,undefined
[5] Cancer Healthcare Research Branch,undefined
[6] Research Institute,undefined
[7] National Cancer Center,undefined
[8] Graduate School of Cancer Science and Policy,undefined
[9] National Cancer Center,undefined
[10] National Cancer Control Institute,undefined
[11] National Cancer Center,undefined
来源：
BMC Cancer | / 18卷
关键词：
Second primary; Ovarian cancer; Primary peritoneal cancer; Fallopian tubal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Niraparib in the maintenance treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: safety and efficacy
    Liu, Marisa C.
    Sutedja, Joyce
    Tewari, Krishnansu S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (05) : 475 - 480
  • [32] Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An updated series
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S155 - S155
  • [33] MANAGEMENT OF PERITONEAL METASTASES IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA
    Gao, Yunong
    ANTICANCER RESEARCH, 2015, 35 (07) : 4301 - 4302
  • [34] Declining Second Primary Ovarian Cancer After First Primary Breast Cancer
    Schonfeld, Sara J.
    de Gonzalez, Amy Berrington
    Visvanathan, Kala
    Pfeiffer, Ruth M.
    Anderson, William F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 738 - 743
  • [35] The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
    F. Zeppernick
    I. Meinhold-Heerlein
    Archives of Gynecology and Obstetrics, 2014, 290 : 839 - 842
  • [36] The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
    Zeppernick, F.
    Meinhold-Heerlein, I.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (05) : 839 - 842
  • [37] The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications
    Duska, L. R.
    Kohn, E. C.
    ANNALS OF ONCOLOGY, 2017, 28 : 8 - 12
  • [38] NEW MAINTENANCE TREATMENT FOR RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2018, 118 (08) : 25 - 26
  • [39] Gemcitabine plus cisplatin in recurrent ovarian, fallopian tube, and primary peritoneal cancer
    Eyada, Mostafa
    Fellman, Bryan M.
    Patel, Shrina
    Michael, Victoria
    Soliman, Pamela T.
    Sims, Travis T.
    How, Jeffrey Andrew
    Jazaeri, Amir A.
    Fleming, Nicole D.
    Ramondetta, Lois M.
    Westin, Shannon Neville
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Sohita Dhillon
    BioDrugs, 2013, 27 : 375 - 392
12345